BALAXI PHARMACEUTICALS LIMITED (BALAXI) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.063x

Based on the latest financial reports, BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a cash flow conversion efficiency ratio of 0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs149.66 Million ≈ $1.62 Million USD) by net assets (Rs2.38 Billion ≈ $25.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

BALAXI PHARMACEUTICALS LIMITED - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how BALAXI PHARMACEUTICALS LIMITED's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BALAXI liabilities breakdown for a breakdown of total debt and financial obligations.

BALAXI PHARMACEUTICALS LIMITED Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BALAXI PHARMACEUTICALS LIMITED ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ree Automotive Holding Inc NASDAQ:REE	-0.666x
CLEANTEK Industries Inc V:CTEK	0.493x
Pure Resources Ltd AU:PR1	0.000x
N.C. Housing Public Company Limited BK:NCH	0.051x
Dgenx Co. Ltd KQ:113810	0.073x
Nature Wood Group Limited American Depositary Shares NASDAQ:NWGL	-0.103x
MODERN COMMERCE SA ZY-10 F:8F4	0.126x
African Media Entertainment JSE:AME	0.070x

Annual Cash Flow Conversion Efficiency for BALAXI PHARMACEUTICALS LIMITED (2013–2025)

The table below shows the annual cash flow conversion efficiency of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see BALAXI market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs2.32 Billion ≈ $25.06 Million	Rs-377.82 Million ≈ $-4.09 Million	-0.163x	-774.66%
2024-03-31	Rs2.01 Billion ≈ $21.78 Million	Rs48.66 Million ≈ $526.25K	0.024x	-27.26%
2023-03-31	Rs1.83 Billion ≈ $19.78 Million	Rs60.75 Million ≈ $657.02K	0.033x	-88.99%
2022-03-31	Rs1.13 Billion ≈ $12.24 Million	Rs341.44 Million ≈ $3.69 Million	0.302x	+632353.73%
2021-03-31	Rs649.80 Million ≈ $7.03 Million	Rs31.00K ≈ $335.25	0.000x	+100.01%
2020-03-31	Rs277.46 Million ≈ $3.00 Million	Rs-140.62 Million ≈ $-1.52 Million	-0.507x	-18.39%
2019-03-31	Rs35.21 Million ≈ $380.73K	Rs-15.07 Million ≈ $-162.98K	-0.428x	+1.89%
2018-03-31	Rs15.55 Million ≈ $168.13K	Rs-6.78 Million ≈ $-73.35K	-0.436x	-3.84%
2017-03-31	Rs23.59 Million ≈ $255.13K	Rs-9.91 Million ≈ $-107.20K	-0.420x	+88.57%
2016-03-31	Rs314.87K ≈ $3.41K	Rs-1.16 Million ≈ $-12.52K	-3.676x	-156.12%
2015-03-31	Rs322.45K ≈ $3.49K	Rs2.11 Million ≈ $22.84K	6.551x	+2233.63%
2014-03-31	Rs7.80 Million ≈ $84.33K	Rs-2.39 Million ≈ $-25.89K	-0.307x	-171.16%
2013-03-31	Rs7.52 Million ≈ $81.34K	Rs3.25 Million ≈ $35.09K	0.431x	--

About BALAXI PHARMACEUTICALS LIMITED

NSE:BALAXI India Biotechnology

Market Cap

$15.90 Million

Rs1.47 Billion INR

Market Cap Rank

#25690 Global

#1432 in India

Share Price

Rs26.63

Change (1 day)

-0.19%

52-Week Range

Rs15.67 - Rs55.98

All Time High

Rs207.74